Palacos® Bone Cement

With more than 35 years of proven clinical success, Palacos cement stands apart from other bone cements. First, there’s its unique color – green – which lends greater visibility. Available with the addition of Gentamicin, Palacos R+G provides consistent antibiotic distribution and reduced revision risk.1 Its ideal handling characteristics, high viscosity and quick dough time, make it easy to use for orthopaedic replacement procedures. This makes Palacos cement ideal for minimally invasive surgery.

Palacos Boxes

Looks that stand out.
The green color of Palacos Bone Cement provides a clear contrast to bone and tissue for greater visibility. Surgeons have a reduced wait for Palacos cement to “dough-up,” providing them with a long working time.  And, compared to manually mixing the cement with an antibiotic, Palacos R+G provides clinically proven antibiotic protection with a more consistent mixture.

High Visualization
Palacos cement’s green color provides improved visualization
of the cement in comparison to bone. Palacos cement also offers excellent post-operative visualization on x-ray.

Excellent Fatigue Strength
Palacos R and Palacos R+G demonstrate excellent fatigue strength compared to other commercially available cements.2

Cement Canal

Broad Spectrum of Kill
Palacos R+G contains Gentamicin which has a broad spectrum covering gram-positive and gram-negative bacteria.3 As a pre-mixed formulation, Palacos R+G provides a homogenous cement/antibiotic mixture and saves valuable OR time.

Superior Release Characteristics
 Studies show that the release characteristics of Palacos R+G are superior to other bone cements. Palacos R+G provides high local concentration of Gentamicin extending over several days. Even with a comparatively low 0.5 grams of Gentamicin, Palacos R+G releases more antibiotic than other cements containing one gram of antibiotic. 4

Long Clinical History
Compared to other bone cements, Palacos cement stands the test of time with a clinical history of low revision risk.1

Cement Canal


View Product Brochure

References:

1. Malchau H, Herberts P, Söderman P, Odén, A.  Prognosis of Total Hip Replacement: Update and Validation of Results from the Swedish National Hip Arthroplasty Register 1979-1998.  Scientific exhibition presented at the 67th Annual Meeting of the American Academy of Orthopaedic Surgeons; March 15-19, 2000; Orlando, USA.

2. Kühn K.D., Bone Cements. Berlin, Germany.  Springer-Verlag 2000. 

3. Foerster,G.v., Buchholz, H. W., Heinert, K.: Die infizierte H¨uftendoprothese-Spätinfektion nach der 6. postoperativen Woche. In: Cotta, H., Braun, A. (Hrgs.), 124-135, 1988.

4. Wahlig, H.: Über die Freisetzungskinetik von Antibiotika aus Knochenzementen – Ergebnisse vergleichender Untersuchungen in vitro und in vivo.  In: Willert, H.-G., Buchhorn, G (Hrsg.), Aktuelle Probleme in der Chirurgie und Orthopädie, Band 31, Knochenzement, 221-226 (1987).

†  Data on file (Heraeus Kulzer GmbH)

     Palacos® is a trademark of Heraeus Kulzer GmbH
Under license from Heraeus Kulzer GmbH, Hanau, Germany

 Heraeus Medical, Manufactured by Heraeus Kulzer GmbH,
61273 Hanau, Germany